Neuroendocrine differentiation of prostate tumor cells is a process that selects for a highly aggressive tumor cell phenotype and increases the frequency of TIC [47], which may suggest that 5-HT5A activity in part regulates prostate TIC activity. This evidence concerns the gene HTR5A and neoplasm.